Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...
The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...
When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...
The use of antipsychotics for schizophrenia was associated with higher risk for severe cases of COVID-19 and non–COVID-19 respiratory infections but not mild infection.
Although it might be an interesting study, there aren’t any randomized, controlled trials of antipsychotic medications for ...
A new nationwide Danish study published in The Lancet Psychiatry found that individuals with schizophrenia spectrum disorders ...
Credit: Nathan Griffith/Getty Images Federal policies designed to reduce use of antipsychotic medications in nursing homes did not lead to clinically significantly higher rates of schizophrenia ...
The following is a summary of “Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders ...
The study has demonstrated that patients with first-episode psychosis who have not been treated with antipsychotic drugs ...
The two new locally acquired cases are from the same area where the first case was reported last week. In other state news: vaccine hesitancy and the Minnesota measles outbreak; an "epidemic" of ...
Opens in a new tab or window Any patient on a dopamine receptor-blocking medication may develop tardive dyskinesia (TD), though most often the condition is associated with antipsychotic medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback